Wednesday October 26, 2022 | Kaiser Health News

The study will examine whether psychedelics can help with smoking cessation

The National Institutes of Health grant to Johns Hopkins University is the first time in 50 years that a federal grant will be used to study a psychedelic drug as a treatment, NBC News says. Meanwhile, the impact of words and labels related to addiction on health care, among other things, is being discussed.

NBC News: NIH-Funded Psychedelic Study Will Investigate If Hallucinogen Can Help Smokers Quit Smoking

The study, a randomized controlled trial expected to begin later this year, will examine whether psilocybin, the psychedelic compound found in “magic mushrooms,” can help people quit tobacco smoking. Hopkins researchers will lead the study, which is being conducted in collaboration with researchers at NYU Langone Health and the University of Alabama at Birmingham. (Syal, 10/26)

More on drug use and addiction —

Statistic: When it comes to addiction, word choice is part of the problem

Who Gets Better Medical Care in the US: “Addicts” or “People with Substance Use Disorders”? Functionally, of course, the terms mean the same thing. But in the field of addiction medicine, the question is something of a crisis. (Fach, 26.10.)

New Haven Independent: New CT school policy for stoned students: Send them to the hospital

Should showing up to school stoned mean you should be taken to the hospital by ambulance? In New Haven, a charter school on Dixwell Avenue said yes. (McFadden, 25.10.)

USA Today: Lawsuit finds corporations liable for Nashville children’s opioid addiction

Six Nashville children who were born addicted to opioids and are now between the ages of 2 and 8 are suing leading opioid companies including Endo and Johnson & Johnson, as well as pharmacies CVS, Rite Aid and Walgreens. (Timms, 25.10.)

In Other Health and Wellness News —

AP: The recall of sleep apnea devices is dragging on and fueling frustration

A massive recall of millions of sleep apnea devices has fueled anger and frustration among patients, and US officials are considering unprecedented legal action to expedite a replacement effort that is expected to stretch into the next year. … Philips originally expected to be able to repair or replace the devices within a year. But with the recall expanding to more than 5 million devices worldwide, the Dutch company now says the effort will stretch into 2023. This left many patients with a choice between using a potentially harmful device or trying risky medicines. (Perrone, 25.10.)

NPR: Study: Most teens who start puberty suppression continue with gender-affirming nursing

A large majority of transgender teens who received puberty suppression treatment continued with gender-affirming treatment, a new study from the Netherlands has found. (Wamsley, 10/26)

USA Today: Climate Change Worsens Health and Inequalities: What Can Be Done?

Researchers around the world are collaborating to examine climate and health in an annual report, the Lancet medical journal’s “countdown” on health and climate change. In this year’s US portion of the report, released Tuesday, scientists break down research on the health effects of a warming climate and outline policy recommendations focused on health equity. (Hassanein, 25.10.)


Leave a Reply

Your email address will not be published. Required fields are marked *